Review



gabaar α4 antibody  (StressMarq)


Bioz Verified Symbol StressMarq is a verified supplier
Bioz Manufacturer Symbol StressMarq manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    StressMarq gabaar α4 antibody
    Gabaar α4 Antibody, supplied by StressMarq, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gabaar+%CE%B14+antibody/GABA-A+Receptor+Alpha+4+Antibody/pm40623672-82-113-119
    Average 93 stars, based on 3 article reviews
    gabaar α4 antibody - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: An integrated pharmacochemical analysis and investigation of the effects of Jingqianshu granules on premenstrual dysphoric disorder (PMDD).
    Article Snippet: Ethnopharmacological relevance: Jingqianshu Granules (JQS) is a traditional Chinese medicine (TCM) compound formula originally used to alleviate symptoms of premenstrual syndrome (PMS).. Its relevance has become increasingly prominent in the context of premenstrual dysphoric disorder (PMDD), a severe, mood-focused subtype of PMS marked by significant emotional and behavioral disturbances that disrupt daily functioning.. JQS holds promising potential for managing PMDD through its multi-component, multi-target therapeutic actions.



    Similar Products

    gabaar α4 antibody  (StressMarq)
    93
    StressMarq gabaar α4 antibody
    Gabaar α4 Antibody, supplied by StressMarq, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gabaar+%CE%B14+antibody/GABA-A+Receptor+Alpha+4+Antibody/pm40623672-82-113-119
    Average 93 stars, based on 1 article reviews
    gabaar α4 antibody - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    rabbit anti gabaar a4  (Alomone Labs)
    92
    Alomone Labs rabbit anti gabaar a4
    Rabbit Anti Gabaar A4, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gabaar+%CE%B14+antibody/Anti-GABA(A)+%CE%B14+Receptor+(extracellular)+Antibody/pm39357522-973-0-27
    Average 92 stars, based on 1 article reviews
    rabbit anti gabaar a4 - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier
    gabaar α4  (Alomone Labs)
    92
    Alomone Labs gabaar α4
    Figure 1. Representative confocal immunofluorescence images demonstrating expression of <t>GABAAR</t> α1 in the stargazer primary SoCx. 10× (Objective: 10× Plan) magnification from control (NE) littermate and epileptic (E) stargazer are shown here. (A) Pseudo-green channel shows diffuse labelling for GABAAR α1 subunit across the cortical layers with higher intensity in layer IV. (B) Pseudo-red channel shows labelling for PV+ neurons. The soma of PV+ neurons are present in all layers except layer I. (C) Pseudo-blue channel shows VGlut2 which assists in identification of the cortical layers. Intense labelling can be seen, predominantly, in layer IV due to the presence of thalamocortical excitatory nerve terminals.
    Gabaar α4, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gabaar+%CE%B14+antibody/Anti-GABA(A)+%CE%B14+Receptor+(extracellular)+Antibody/pm36555327-323-18-22
    Average 92 stars, based on 1 article reviews
    gabaar α4 - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier
    primary antibody directed against the α4-subunit of gabaa receptor (gabaar)  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology primary antibody directed against the α4-subunit of gabaa receptor (gabaar)
    Figure 1. Representative confocal immunofluorescence images demonstrating expression of <t>GABAAR</t> α1 in the stargazer primary SoCx. 10× (Objective: 10× Plan) magnification from control (NE) littermate and epileptic (E) stargazer are shown here. (A) Pseudo-green channel shows diffuse labelling for GABAAR α1 subunit across the cortical layers with higher intensity in layer IV. (B) Pseudo-red channel shows labelling for PV+ neurons. The soma of PV+ neurons are present in all layers except layer I. (C) Pseudo-blue channel shows VGlut2 which assists in identification of the cortical layers. Intense labelling can be seen, predominantly, in layer IV due to the presence of thalamocortical excitatory nerve terminals.
    Primary Antibody Directed Against The α4 Subunit Of Gabaa Receptor (Gabaar), supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gabaar+%CE%B14+antibody/antibodies+against+gaba+a+receptor+subunits/pm29684457-91-6-14
    Average 90 stars, based on 1 article reviews
    primary antibody directed against the α4-subunit of gabaa receptor (gabaar) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    rabbit polyclonal gabaar a4 subunit antibody  (Alomone Labs)
    92
    Alomone Labs rabbit polyclonal gabaar a4 subunit antibody
    Figure 1. Representative confocal immunofluorescence images demonstrating expression of <t>GABAAR</t> α1 in the stargazer primary SoCx. 10× (Objective: 10× Plan) magnification from control (NE) littermate and epileptic (E) stargazer are shown here. (A) Pseudo-green channel shows diffuse labelling for GABAAR α1 subunit across the cortical layers with higher intensity in layer IV. (B) Pseudo-red channel shows labelling for PV+ neurons. The soma of PV+ neurons are present in all layers except layer I. (C) Pseudo-blue channel shows VGlut2 which assists in identification of the cortical layers. Intense labelling can be seen, predominantly, in layer IV due to the presence of thalamocortical excitatory nerve terminals.
    Rabbit Polyclonal Gabaar A4 Subunit Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gabaar+%CE%B14+antibody/Anti-GABA+%CE%B14+Receptor+Antibody/pm26297893-91-5-13
    Average 92 stars, based on 1 article reviews
    rabbit polyclonal gabaar a4 subunit antibody - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 1. Representative confocal immunofluorescence images demonstrating expression of GABAAR α1 in the stargazer primary SoCx. 10× (Objective: 10× Plan) magnification from control (NE) littermate and epileptic (E) stargazer are shown here. (A) Pseudo-green channel shows diffuse labelling for GABAAR α1 subunit across the cortical layers with higher intensity in layer IV. (B) Pseudo-red channel shows labelling for PV+ neurons. The soma of PV+ neurons are present in all layers except layer I. (C) Pseudo-blue channel shows VGlut2 which assists in identification of the cortical layers. Intense labelling can be seen, predominantly, in layer IV due to the presence of thalamocortical excitatory nerve terminals.

    Journal: International journal of molecular sciences

    Article Title: Altered GABA A Receptor Expression in the Primary Somatosensory Cortex of a Mouse Model of Genetic Absence Epilepsy.

    doi: 10.3390/ijms232415685

    Figure Lengend Snippet: Figure 1. Representative confocal immunofluorescence images demonstrating expression of GABAAR α1 in the stargazer primary SoCx. 10× (Objective: 10× Plan) magnification from control (NE) littermate and epileptic (E) stargazer are shown here. (A) Pseudo-green channel shows diffuse labelling for GABAAR α1 subunit across the cortical layers with higher intensity in layer IV. (B) Pseudo-red channel shows labelling for PV+ neurons. The soma of PV+ neurons are present in all layers except layer I. (C) Pseudo-blue channel shows VGlut2 which assists in identification of the cortical layers. Intense labelling can be seen, predominantly, in layer IV due to the presence of thalamocortical excitatory nerve terminals.

    Article Snippet: Membranes were probed using GABAAR α1 (1:500; AGA-001, Alomone, Jerusalem, Israel), GABAAR α3 (1:500; AGA-003, Alomone, Jerusalem, Israel), GABAAR α4 (1:200; AGA-008, Alomone, Jerusalem, Israel), GABAAR α5 (1:1000; AB9678, Sigma-Aldrich, St. Louis, MO, USA), GABAAR β2 (1:1000; ab8340, Abcam, Cambridge, UK), GABAAR β3 (1:1000; ab4046, Abcam, Cambridge, UK), GABAAR γ2 (1:200; AGA-005, Alomone, Jerusalem, Israel), and GABAAR δ (1:200; AGA014, Alomone, Jerusalem, Israel) with β-actin (1:1000; ab8226, Abcam, Cambridge UK) used Int.

    Techniques: Expressing, Control

    Figure 2. Merged confocal immunofluorescence images demonstrating the co-labelling for GABAAR α1 and PV in the primary SoCx of control (NE) littermate and epileptic (E) stargazer. (A) 10× magnification of GABAAR α1/PV merged image shows co-localization of GABAAR α1 with PV+ somas and processes. (B) 60× (Objective: 60× PlanApo oil) magnification of GABAAR α1/PV merged image clearly shows GABAAR α1 present throughout the cortex as well on PV somas.

    Journal: International journal of molecular sciences

    Article Title: Altered GABA A Receptor Expression in the Primary Somatosensory Cortex of a Mouse Model of Genetic Absence Epilepsy.

    doi: 10.3390/ijms232415685

    Figure Lengend Snippet: Figure 2. Merged confocal immunofluorescence images demonstrating the co-labelling for GABAAR α1 and PV in the primary SoCx of control (NE) littermate and epileptic (E) stargazer. (A) 10× magnification of GABAAR α1/PV merged image shows co-localization of GABAAR α1 with PV+ somas and processes. (B) 60× (Objective: 60× PlanApo oil) magnification of GABAAR α1/PV merged image clearly shows GABAAR α1 present throughout the cortex as well on PV somas.

    Article Snippet: Membranes were probed using GABAAR α1 (1:500; AGA-001, Alomone, Jerusalem, Israel), GABAAR α3 (1:500; AGA-003, Alomone, Jerusalem, Israel), GABAAR α4 (1:200; AGA-008, Alomone, Jerusalem, Israel), GABAAR α5 (1:1000; AB9678, Sigma-Aldrich, St. Louis, MO, USA), GABAAR β2 (1:1000; ab8340, Abcam, Cambridge, UK), GABAAR β3 (1:1000; ab4046, Abcam, Cambridge, UK), GABAAR γ2 (1:200; AGA-005, Alomone, Jerusalem, Israel), and GABAAR δ (1:200; AGA014, Alomone, Jerusalem, Israel) with β-actin (1:1000; ab8226, Abcam, Cambridge UK) used Int.

    Techniques: Control

    Figure 3. WB analysis for GABAAR α1 and α3 subunits in the primary SoCx. Data compare expression between control (NE) littermates and epileptic (E) stargazers. (A) Representative blots display GABAAR α1 in the primary SoCx with β-actin as the loading control. Bar graphs represent the relative expression levels of GABAAR α1 (mean ± SEM). WB analysis revealed a statistically significant reduction in whole-tissue expression levels of GABAAR α1 in the primary SoCx of the stargazers (NE: 0.960 ± 0.066 [n = 18], E: 0.78 ± 0.046 [n = 14], p = 0.041); (B) Representative blots display GABAAR α3 in the primary SoCx with β-actin as the loading control. Bar graphs represent the relative expression levels of GABAAR α3. There was no statistically significant change in whole-tissue expression levels of GABAAR α3 in the primary SoCx of the stargazers (NE: 1.000 ± 0.036 [n = 17], E: 0.935 ± 0.049 [n = 15], p = 0.519). The significance threshold was set at 0.05 with * indicating p < 0.05. ‘ns’ indicates no significant change found from analyses.

    Journal: International journal of molecular sciences

    Article Title: Altered GABA A Receptor Expression in the Primary Somatosensory Cortex of a Mouse Model of Genetic Absence Epilepsy.

    doi: 10.3390/ijms232415685

    Figure Lengend Snippet: Figure 3. WB analysis for GABAAR α1 and α3 subunits in the primary SoCx. Data compare expression between control (NE) littermates and epileptic (E) stargazers. (A) Representative blots display GABAAR α1 in the primary SoCx with β-actin as the loading control. Bar graphs represent the relative expression levels of GABAAR α1 (mean ± SEM). WB analysis revealed a statistically significant reduction in whole-tissue expression levels of GABAAR α1 in the primary SoCx of the stargazers (NE: 0.960 ± 0.066 [n = 18], E: 0.78 ± 0.046 [n = 14], p = 0.041); (B) Representative blots display GABAAR α3 in the primary SoCx with β-actin as the loading control. Bar graphs represent the relative expression levels of GABAAR α3. There was no statistically significant change in whole-tissue expression levels of GABAAR α3 in the primary SoCx of the stargazers (NE: 1.000 ± 0.036 [n = 17], E: 0.935 ± 0.049 [n = 15], p = 0.519). The significance threshold was set at 0.05 with * indicating p < 0.05. ‘ns’ indicates no significant change found from analyses.

    Article Snippet: Membranes were probed using GABAAR α1 (1:500; AGA-001, Alomone, Jerusalem, Israel), GABAAR α3 (1:500; AGA-003, Alomone, Jerusalem, Israel), GABAAR α4 (1:200; AGA-008, Alomone, Jerusalem, Israel), GABAAR α5 (1:1000; AB9678, Sigma-Aldrich, St. Louis, MO, USA), GABAAR β2 (1:1000; ab8340, Abcam, Cambridge, UK), GABAAR β3 (1:1000; ab4046, Abcam, Cambridge, UK), GABAAR γ2 (1:200; AGA-005, Alomone, Jerusalem, Israel), and GABAAR δ (1:200; AGA014, Alomone, Jerusalem, Israel) with β-actin (1:1000; ab8226, Abcam, Cambridge UK) used Int.

    Techniques: Expressing, Control

    Figure 4. WB analysis for GABAAR β2, β3, and γ2 subunits in the primary SoCx. The data compare expression between control (NE) littermates and epileptic (E) stargazers. (A–C) Representative blots display tissue expression of GABAAR β2, β3, and γ2 subunits in the primary SoCx with β-actin as the loading control. Bar graphs represent the relative expression levels of GABAAR β2, β3, and γ2 subunits, respectively. Bar graphs show a lack of statistically significant change in whole-tissue primary SoCx expression levels for β2 (NE: 0.917 ± 0.091 [n = 12], E: 0.678 ± 0.050 [n = 10]; p = 0.093), β3 (NE: 1.000 ± 0.067 [n = 12], E: 1.070 ± 0.109 [n = 10]; p = 0.859), and γ2 (NE: 1.000 ± 0.159 [n = 9], E: 0.946 ± 0.079 [n = 7]; p = 0.900). The significance threshold was set at 0.05. ‘ns’ indicates no significant change found from analyses.

    Journal: International journal of molecular sciences

    Article Title: Altered GABA A Receptor Expression in the Primary Somatosensory Cortex of a Mouse Model of Genetic Absence Epilepsy.

    doi: 10.3390/ijms232415685

    Figure Lengend Snippet: Figure 4. WB analysis for GABAAR β2, β3, and γ2 subunits in the primary SoCx. The data compare expression between control (NE) littermates and epileptic (E) stargazers. (A–C) Representative blots display tissue expression of GABAAR β2, β3, and γ2 subunits in the primary SoCx with β-actin as the loading control. Bar graphs represent the relative expression levels of GABAAR β2, β3, and γ2 subunits, respectively. Bar graphs show a lack of statistically significant change in whole-tissue primary SoCx expression levels for β2 (NE: 0.917 ± 0.091 [n = 12], E: 0.678 ± 0.050 [n = 10]; p = 0.093), β3 (NE: 1.000 ± 0.067 [n = 12], E: 1.070 ± 0.109 [n = 10]; p = 0.859), and γ2 (NE: 1.000 ± 0.159 [n = 9], E: 0.946 ± 0.079 [n = 7]; p = 0.900). The significance threshold was set at 0.05. ‘ns’ indicates no significant change found from analyses.

    Article Snippet: Membranes were probed using GABAAR α1 (1:500; AGA-001, Alomone, Jerusalem, Israel), GABAAR α3 (1:500; AGA-003, Alomone, Jerusalem, Israel), GABAAR α4 (1:200; AGA-008, Alomone, Jerusalem, Israel), GABAAR α5 (1:1000; AB9678, Sigma-Aldrich, St. Louis, MO, USA), GABAAR β2 (1:1000; ab8340, Abcam, Cambridge, UK), GABAAR β3 (1:1000; ab4046, Abcam, Cambridge, UK), GABAAR γ2 (1:200; AGA-005, Alomone, Jerusalem, Israel), and GABAAR δ (1:200; AGA014, Alomone, Jerusalem, Israel) with β-actin (1:1000; ab8226, Abcam, Cambridge UK) used Int.

    Techniques: Expressing, Control

    Figure 5. WB analysis for the principal tonic GABAAR α4, α5, and δ subunits. Analysis compares the primary SoCx of control (NE) littermates and the epileptic (E) stargazers. (A–C) Representative blots display tissue expression of GABAAR α4, α5, and δ subunits in the primary SoCx with β-actin as the loading control. Bar graphs represent the relative expression levels of GABAAR α4, α5 and δ subunits, respectively. Bar graphs reveal a lack of statistically significant change in whole-tissue primary SoCx expression levels for GABAAR α4 (NE: 1.000 ± 0.063 [n = 18], E: 1.117 ± 0.095 [n = 15]; p = 0.325), α5 (NE: 1.000 ± 0.048 [n = 23], E: 0.937 ± 0.083 [n = 13]; p = 0.672), and δ (NE: 1.000 ± 0.041 [n = 27], E: 0.899 ± 0.069 [n = 23]; p = 0.215). The significance threshold was set at 0.05. ‘ns’ indicates no significant change found from analyses.

    Journal: International journal of molecular sciences

    Article Title: Altered GABA A Receptor Expression in the Primary Somatosensory Cortex of a Mouse Model of Genetic Absence Epilepsy.

    doi: 10.3390/ijms232415685

    Figure Lengend Snippet: Figure 5. WB analysis for the principal tonic GABAAR α4, α5, and δ subunits. Analysis compares the primary SoCx of control (NE) littermates and the epileptic (E) stargazers. (A–C) Representative blots display tissue expression of GABAAR α4, α5, and δ subunits in the primary SoCx with β-actin as the loading control. Bar graphs represent the relative expression levels of GABAAR α4, α5 and δ subunits, respectively. Bar graphs reveal a lack of statistically significant change in whole-tissue primary SoCx expression levels for GABAAR α4 (NE: 1.000 ± 0.063 [n = 18], E: 1.117 ± 0.095 [n = 15]; p = 0.325), α5 (NE: 1.000 ± 0.048 [n = 23], E: 0.937 ± 0.083 [n = 13]; p = 0.672), and δ (NE: 1.000 ± 0.041 [n = 27], E: 0.899 ± 0.069 [n = 23]; p = 0.215). The significance threshold was set at 0.05. ‘ns’ indicates no significant change found from analyses.

    Article Snippet: Membranes were probed using GABAAR α1 (1:500; AGA-001, Alomone, Jerusalem, Israel), GABAAR α3 (1:500; AGA-003, Alomone, Jerusalem, Israel), GABAAR α4 (1:200; AGA-008, Alomone, Jerusalem, Israel), GABAAR α5 (1:1000; AB9678, Sigma-Aldrich, St. Louis, MO, USA), GABAAR β2 (1:1000; ab8340, Abcam, Cambridge, UK), GABAAR β3 (1:1000; ab4046, Abcam, Cambridge, UK), GABAAR γ2 (1:200; AGA-005, Alomone, Jerusalem, Israel), and GABAAR δ (1:200; AGA014, Alomone, Jerusalem, Israel) with β-actin (1:1000; ab8226, Abcam, Cambridge UK) used Int.

    Techniques: Control, Expressing

    Figure 6. Pilot WB run for biochemically isolated primary SoCx subcellular fractions (total lysate, cytosol, extra-synaptic and synaptic). This run confirmed the successful isolation of the synaptic fractions given the intense labelling for both PSD95 and GABAAR α1. Extra-synaptic fraction, on the other hand, showed no bands for PSD95, but low intensity bands were seen for GABAAR α1 and β-actin. PanC showed good expression in all subcellular fractions.

    Journal: International journal of molecular sciences

    Article Title: Altered GABA A Receptor Expression in the Primary Somatosensory Cortex of a Mouse Model of Genetic Absence Epilepsy.

    doi: 10.3390/ijms232415685

    Figure Lengend Snippet: Figure 6. Pilot WB run for biochemically isolated primary SoCx subcellular fractions (total lysate, cytosol, extra-synaptic and synaptic). This run confirmed the successful isolation of the synaptic fractions given the intense labelling for both PSD95 and GABAAR α1. Extra-synaptic fraction, on the other hand, showed no bands for PSD95, but low intensity bands were seen for GABAAR α1 and β-actin. PanC showed good expression in all subcellular fractions.

    Article Snippet: Membranes were probed using GABAAR α1 (1:500; AGA-001, Alomone, Jerusalem, Israel), GABAAR α3 (1:500; AGA-003, Alomone, Jerusalem, Israel), GABAAR α4 (1:200; AGA-008, Alomone, Jerusalem, Israel), GABAAR α5 (1:1000; AB9678, Sigma-Aldrich, St. Louis, MO, USA), GABAAR β2 (1:1000; ab8340, Abcam, Cambridge, UK), GABAAR β3 (1:1000; ab4046, Abcam, Cambridge, UK), GABAAR γ2 (1:200; AGA-005, Alomone, Jerusalem, Israel), and GABAAR δ (1:200; AGA014, Alomone, Jerusalem, Israel) with β-actin (1:1000; ab8226, Abcam, Cambridge UK) used Int.

    Techniques: Isolation, Expressing

    Figure 7. WB analyses of biochemically isolated fractions from the primary SoCx for GABAAR α1 and α3 subunits. Isolated subcellular fractions were compared between control (NE) litter- mates and epileptic (E) stargazers. (A–D) Biochemical fractionation analysis revealed a 12.2% reduction in the synaptic expression of phasic GABAAR α1 in the primary SoCx of the stargaz- ers compared to their control littermates (NE: 1.000 ± 0.146 [n = 10], E: 0.878 ± 0.037 [n = 10]; p = 0.002); no significant difference was revealed from the other subcellular components: total lysate (NE: 1.000 ± 0.043 [n = 7], E: 0.961 ± 0.052 [n = 6]; p = 0.531), cytosol (NE: 1.000 ± 0.034 [n = 7], E: 1.100 ± 0.098 [n = 6]; p = 0.443), and extra-synaptic (NE: 1.000 ± 0.074 [n = 9], E: 0.912 ± 0.094 [n = 9]; p = 0.385). (E–H) Biochemical fractionation analysis revealed no significant change in GABAAR α3 in all subcellular components from the primary SoCx of stargazers compared to their control littermates: Total lysate (NE: 1.000 ± 0.026 [n = 12], E: 1.035 ± 0.060 [n = 10]; p = 0.381), cytosol (NE: 1.000 ± 0.037 [n = 11], E: 1.181 ± 0.118 [n = 10]; p = 0.349), extra-synaptic (NE: 1.000 ± 0.031 [n = 11], E: 1.093 ± 0.125 [n = 11]; p = 0.133), and synaptic (NE: 0.967 ± 0.034 [n = 11], E: 1.205 ± 0.153 [n = 9], p = 0.359). The sig- nificance threshold was set at 0.05 with ** indicating p < 0.01. ‘ns’ indicates no significant change found from analyses.

    Journal: International journal of molecular sciences

    Article Title: Altered GABA A Receptor Expression in the Primary Somatosensory Cortex of a Mouse Model of Genetic Absence Epilepsy.

    doi: 10.3390/ijms232415685

    Figure Lengend Snippet: Figure 7. WB analyses of biochemically isolated fractions from the primary SoCx for GABAAR α1 and α3 subunits. Isolated subcellular fractions were compared between control (NE) litter- mates and epileptic (E) stargazers. (A–D) Biochemical fractionation analysis revealed a 12.2% reduction in the synaptic expression of phasic GABAAR α1 in the primary SoCx of the stargaz- ers compared to their control littermates (NE: 1.000 ± 0.146 [n = 10], E: 0.878 ± 0.037 [n = 10]; p = 0.002); no significant difference was revealed from the other subcellular components: total lysate (NE: 1.000 ± 0.043 [n = 7], E: 0.961 ± 0.052 [n = 6]; p = 0.531), cytosol (NE: 1.000 ± 0.034 [n = 7], E: 1.100 ± 0.098 [n = 6]; p = 0.443), and extra-synaptic (NE: 1.000 ± 0.074 [n = 9], E: 0.912 ± 0.094 [n = 9]; p = 0.385). (E–H) Biochemical fractionation analysis revealed no significant change in GABAAR α3 in all subcellular components from the primary SoCx of stargazers compared to their control littermates: Total lysate (NE: 1.000 ± 0.026 [n = 12], E: 1.035 ± 0.060 [n = 10]; p = 0.381), cytosol (NE: 1.000 ± 0.037 [n = 11], E: 1.181 ± 0.118 [n = 10]; p = 0.349), extra-synaptic (NE: 1.000 ± 0.031 [n = 11], E: 1.093 ± 0.125 [n = 11]; p = 0.133), and synaptic (NE: 0.967 ± 0.034 [n = 11], E: 1.205 ± 0.153 [n = 9], p = 0.359). The sig- nificance threshold was set at 0.05 with ** indicating p < 0.01. ‘ns’ indicates no significant change found from analyses.

    Article Snippet: Membranes were probed using GABAAR α1 (1:500; AGA-001, Alomone, Jerusalem, Israel), GABAAR α3 (1:500; AGA-003, Alomone, Jerusalem, Israel), GABAAR α4 (1:200; AGA-008, Alomone, Jerusalem, Israel), GABAAR α5 (1:1000; AB9678, Sigma-Aldrich, St. Louis, MO, USA), GABAAR β2 (1:1000; ab8340, Abcam, Cambridge, UK), GABAAR β3 (1:1000; ab4046, Abcam, Cambridge, UK), GABAAR γ2 (1:200; AGA-005, Alomone, Jerusalem, Israel), and GABAAR δ (1:200; AGA014, Alomone, Jerusalem, Israel) with β-actin (1:1000; ab8226, Abcam, Cambridge UK) used Int.

    Techniques: Isolation, Control, Fractionation, Expressing

    Figure 8. WB analyses of biochemically isolated fractions from primary SoCx for GABAAR α4, α5, and δ subunits. Subcellular fractions were isolated from the control (NE) littermates and epileptic epileptic (E) stargazers. (A–D) Biochemical fractionation analysis revealed no signif- icant change in GABAAR α4 in all subcellular components from the primary SoCx of stargaz- ers compared to their NE littermates: total lysate (NE: 1.000 ± 0.063 [n = 9], E: 1.353 ± 0.227 [n = 9]; p = 0.257), cytosol (NE: 1.000 ± 0.088 [n = 14], E: 1.308 ± 0.223 [n = 10]; p = 0.172), extra-synaptic (NE: 1.000 ± 0.051 [n = 14], E: 0.789 ± 0.183 [n = 9]; p = 0.516), and synaptic (NE: 1.000 ± 0.047 [n = 14], E: 0.955 ± 0.122 [n = 9]; p = 0.369). (E–H) GABAAR α5 anal- ysis revealed no significant change in all subcellular components from the primary SoCx of stargazers compared to their control littermates: total lysate (NE: 1.000 ± 0.094 [n = 10], E: 0.919 ± 0.102 [n = 10]; p = 0.566), cytosol (NE: 1.000 ± 0.113 [n = 14], E: 1.295 ± 0.362 [n = 8]; p = 0.920), extra-synaptic (NE: 1.000 ± 0.068 [n = 13], E: 1.324 ± 0.214 [n = 9]; p = 0.431) and, synaptic (NE: 1.000 ± 0.075 [n = 13], E: 1.190 ± 0.195 [n = 9]; p = 0.744). (I–L) No statistically significant change was also seen for GABAAR δ subunit in all subcellular compo- nents from the primary SoCx of stargazers compared to their control littermates: total lysate (NE:1.000 ± 0.071 [n = 15], E: 1.088 ± 0.201 [n = 9]; p = 0.815), cytosol (NE: 1.000 ± 0.083 [n = 15], E: 0.831 ± 0.138 [n = 9]; p = 0.379), extra-synaptic (NE: 1.000 ± 0.078 [n = 15], E: 1.419 ± 0.241 [n = 10]; p = 0.191), and synaptic (NE: 1.000 ± 0.053 [n = 15], E: 1.092 ± 0.094 [n = 9]; p = 0.263). The significance threshold was set at 0.05. ‘ns’ indicates no significant change found from analyses.

    Journal: International journal of molecular sciences

    Article Title: Altered GABA A Receptor Expression in the Primary Somatosensory Cortex of a Mouse Model of Genetic Absence Epilepsy.

    doi: 10.3390/ijms232415685

    Figure Lengend Snippet: Figure 8. WB analyses of biochemically isolated fractions from primary SoCx for GABAAR α4, α5, and δ subunits. Subcellular fractions were isolated from the control (NE) littermates and epileptic epileptic (E) stargazers. (A–D) Biochemical fractionation analysis revealed no signif- icant change in GABAAR α4 in all subcellular components from the primary SoCx of stargaz- ers compared to their NE littermates: total lysate (NE: 1.000 ± 0.063 [n = 9], E: 1.353 ± 0.227 [n = 9]; p = 0.257), cytosol (NE: 1.000 ± 0.088 [n = 14], E: 1.308 ± 0.223 [n = 10]; p = 0.172), extra-synaptic (NE: 1.000 ± 0.051 [n = 14], E: 0.789 ± 0.183 [n = 9]; p = 0.516), and synaptic (NE: 1.000 ± 0.047 [n = 14], E: 0.955 ± 0.122 [n = 9]; p = 0.369). (E–H) GABAAR α5 anal- ysis revealed no significant change in all subcellular components from the primary SoCx of stargazers compared to their control littermates: total lysate (NE: 1.000 ± 0.094 [n = 10], E: 0.919 ± 0.102 [n = 10]; p = 0.566), cytosol (NE: 1.000 ± 0.113 [n = 14], E: 1.295 ± 0.362 [n = 8]; p = 0.920), extra-synaptic (NE: 1.000 ± 0.068 [n = 13], E: 1.324 ± 0.214 [n = 9]; p = 0.431) and, synaptic (NE: 1.000 ± 0.075 [n = 13], E: 1.190 ± 0.195 [n = 9]; p = 0.744). (I–L) No statistically significant change was also seen for GABAAR δ subunit in all subcellular compo- nents from the primary SoCx of stargazers compared to their control littermates: total lysate (NE:1.000 ± 0.071 [n = 15], E: 1.088 ± 0.201 [n = 9]; p = 0.815), cytosol (NE: 1.000 ± 0.083 [n = 15], E: 0.831 ± 0.138 [n = 9]; p = 0.379), extra-synaptic (NE: 1.000 ± 0.078 [n = 15], E: 1.419 ± 0.241 [n = 10]; p = 0.191), and synaptic (NE: 1.000 ± 0.053 [n = 15], E: 1.092 ± 0.094 [n = 9]; p = 0.263). The significance threshold was set at 0.05. ‘ns’ indicates no significant change found from analyses.

    Article Snippet: Membranes were probed using GABAAR α1 (1:500; AGA-001, Alomone, Jerusalem, Israel), GABAAR α3 (1:500; AGA-003, Alomone, Jerusalem, Israel), GABAAR α4 (1:200; AGA-008, Alomone, Jerusalem, Israel), GABAAR α5 (1:1000; AB9678, Sigma-Aldrich, St. Louis, MO, USA), GABAAR β2 (1:1000; ab8340, Abcam, Cambridge, UK), GABAAR β3 (1:1000; ab4046, Abcam, Cambridge, UK), GABAAR γ2 (1:200; AGA-005, Alomone, Jerusalem, Israel), and GABAAR δ (1:200; AGA014, Alomone, Jerusalem, Israel) with β-actin (1:1000; ab8226, Abcam, Cambridge UK) used Int.

    Techniques: Isolation, Control, Fractionation

    Figure 9. ICC-EM analysis for GABAAR α1 at PV+ and non-PV inhibitory synapses in the primary SoCx compared and analyzed between control (NE) littermates and epileptic (E) stargazers. From top to bottom: Representative EM micrographs demonstrate PV labelling in the presynaptic terminals (pre), which appear darker stained, in stargazer and NE littermate primary SoCx. Arrow represents 20 nm immunogold particle labelling PV while arrowhead represents 10 nm immunogold labelling GABAAR α1. (A) For analysis for GABAAR α1 at inhibitory synapses from non-PV terminals onto non-PV profiles, as indicated by lack of 20 nm gold particles, 490 synapses in stargazers and 490 in control littermates primary SoCx were analyzed from seven pairs distributed equally. No significant difference was seen in the seven pairs (NE: 10.65 ± 0.918 [n = 7], E: 10.72 ± 0.751 [n = 7]; p = 0.804). (B) Analysis for GABAAR α1 at inhibitory synapses with PV (20 nm gold) in the presynaptic terminals revealed no significant difference between the stargazers (63 synapses analyzed) and control littermates (63 synapses analyzed) (NE: 11.82 ± 1.325 [n = 7], E: 11.15 ± 1.007 [n = 7], p > 0.999). The significance threshold was set at 0.05. ‘ns’ indicates no significant change found from analyses.

    Journal: International journal of molecular sciences

    Article Title: Altered GABA A Receptor Expression in the Primary Somatosensory Cortex of a Mouse Model of Genetic Absence Epilepsy.

    doi: 10.3390/ijms232415685

    Figure Lengend Snippet: Figure 9. ICC-EM analysis for GABAAR α1 at PV+ and non-PV inhibitory synapses in the primary SoCx compared and analyzed between control (NE) littermates and epileptic (E) stargazers. From top to bottom: Representative EM micrographs demonstrate PV labelling in the presynaptic terminals (pre), which appear darker stained, in stargazer and NE littermate primary SoCx. Arrow represents 20 nm immunogold particle labelling PV while arrowhead represents 10 nm immunogold labelling GABAAR α1. (A) For analysis for GABAAR α1 at inhibitory synapses from non-PV terminals onto non-PV profiles, as indicated by lack of 20 nm gold particles, 490 synapses in stargazers and 490 in control littermates primary SoCx were analyzed from seven pairs distributed equally. No significant difference was seen in the seven pairs (NE: 10.65 ± 0.918 [n = 7], E: 10.72 ± 0.751 [n = 7]; p = 0.804). (B) Analysis for GABAAR α1 at inhibitory synapses with PV (20 nm gold) in the presynaptic terminals revealed no significant difference between the stargazers (63 synapses analyzed) and control littermates (63 synapses analyzed) (NE: 11.82 ± 1.325 [n = 7], E: 11.15 ± 1.007 [n = 7], p > 0.999). The significance threshold was set at 0.05. ‘ns’ indicates no significant change found from analyses.

    Article Snippet: Membranes were probed using GABAAR α1 (1:500; AGA-001, Alomone, Jerusalem, Israel), GABAAR α3 (1:500; AGA-003, Alomone, Jerusalem, Israel), GABAAR α4 (1:200; AGA-008, Alomone, Jerusalem, Israel), GABAAR α5 (1:1000; AB9678, Sigma-Aldrich, St. Louis, MO, USA), GABAAR β2 (1:1000; ab8340, Abcam, Cambridge, UK), GABAAR β3 (1:1000; ab4046, Abcam, Cambridge, UK), GABAAR γ2 (1:200; AGA-005, Alomone, Jerusalem, Israel), and GABAAR δ (1:200; AGA014, Alomone, Jerusalem, Israel) with β-actin (1:1000; ab8226, Abcam, Cambridge UK) used Int.

    Techniques: Control, Staining